Keywords: wyeth, unveils, seven, late-stage, drugs, indications, its

Wyeth unveils seven late-stage drugs for 11 indications at its annual R&D presentation

Article | 16 October 2006

Print This

US drug major Wyeth showcased a robust pipeline of late-stage drug candidates, as well as several early-stage compounds, at its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in